High Dose Chemotherapy with Thiotepa, Mitoxantrone and Carboplatin (TMJ) Followed by Autologous Stem Cell Support in 100 Consecutive Lymphoma Patients in a Single Centre: Analysis of Efficacy, Toxicity and Prognostic Factors

References

• Armitage, J.O. (1993) "Treatment of Non-Hodgkin's lymphoma", New England Journal of Medicine, 328, 1023 — 1030.
   PubMed Web of Science ®Google Scholar
• Salles, G., Ship, M.A. and Coiffier, B. (1994) "Chemotherapy of Non-Hodgkin's aggressive lymphoma", Seminars in Hematology, 31, 46–49.
   PubMed Web of Science ®Google Scholar
• Oza, A.M., Ganesan, T.S., Leahy, M., et al. (1993) "Patterns of survival in patients with Hodgkin's disease: long follow up in single centre", Annals of Oncology, 4, 385–392.
   PubMed Web of Science ®Google Scholar
• Specht, L., Gray, R.G., Clarke, M.J. and Petro, R. (1998) "Influence of more extensive radiotherapy and adjuvant chemother-apy on long term outcome of early stage Hodgkin's disease: a meta analysis of 23 randomized trials involving 3,888 patients. Interna-tional Hodgkin's disease collaborative group", Journal of Clinical Oncology, 16, 830–843.
   Web of Science ®Google Scholar
• Philip, T., Guglielmi, C., Hagenbeek, A., Somers, R., Van der Lelie, H., Bron, D., et al. (1995) "Autologous bone marrow transplanta-tion as compared with salvage chemotherapy in relapses of chemotherapy sensitive Non-Hodgkin's lymphoma", New England Journal of Medicine, 333, 1540— 1545.
   Google Scholar
• Haioun, C., Lepage, E., Giselbrecht, C. et al. (2000) "Survival benefit of high dose therapy in poor risk aggressive Non-Hodgkin's lymphoma: Final analysis of prospective LNH87-2 protocol- A Groupe d'Etude des lymphomas de I'Adulte study", Journal of Clinical Oncology, 18, 3025–3030.
   Google Scholar
• Alan, R., Yuen, S.A., Hoppe, R.T., Halpern, J.D. and Horning, S.J. (1997) "Comparison between conventional salvage and high dose therapy with auto-grafting for recurrent or refractory Hodgkin's disease", Blood, 89, 814–822.
   Google Scholar
• Ahmed, T., Lake, D.E., Beer, M., Feldman, E.J., Coleman, M., et al. (1997) "Single and double auto-transplants for relapsing/ refractory Hodgkin's disease: results of two consecutive trials", Bone Marrow Transplantation, 19, 449–454.
   PubMed Web of Science ®Google Scholar
• Dixon, W.J. (1992) BMDP Statistical Software Manual. Los Angeles: University of California Press.
   Google Scholar
• Dixon, W.J. and Massey, F.J. Jr. (1983) Introduction to Statistical Analysis, 4th edn. New York: McGraw-Hill.
   Google Scholar
• NCI (1998) Cancer Therapy Evaluation Program, Common toxicity criteria version 2.0, DCTD, NCI, NIH, DHHS.
   Google Scholar
• Gribben, J.G., Goldstone, A.H., Linch, D.C. et al. (1989) "Effectiveness of high dose combination chemotherapy and auto-logous bone marrow transplantation for patients with non-Hodgkin's lymphoma who are still responsive to conventional dose therapy", Journal of Clinical Oncology, 7, 1621–1629.
   Web of Science ®Google Scholar
• Philip, T., Armitage, J.O., Spitzer, G. et al. (1987) "High dose therapy and autologous transplantation after failure of conven-tional chemotherapy in adults with intermediate grade or high-grade non-Hodgkin's lymphoma", New England Journal of Medicine, 316, 1493–1498.
   Google Scholar
• Stiff, P.J., Dahlberg, S. and Forman, Si. (1998) "Autologous bone marrow transplantation for patients with relapsed or refractory diffuse aggressive non-Hodgkin's lymphoma: value of augmented preparatory regimens- A Southwest Oncology Group Study", Journal of Clinical Oncology, 16, 48–55.
   PubMed Web of Science ®Google Scholar
• Gulati, S., Yahalom, J., Acaba, L. et al. (1992) "Treatment of patients with relapsed or resistant non-Hodgkin's lymphoma using total body irradiation, etoposide, cyclophosphamide and autolo-gous bone marrow transplantation", Journal of Clinical Oncology, 10, 936–941.
   Google Scholar
• Gaspard, M.H., Maraninchi, D., Stoppa, AM. et al. (1998) "Intensive chemotherapy with high dose of BCNU, etoposide, cytosine arabinoside and melphan (BEAM) followed by autologous bone marrow transplantation: Toxicity and anti tumor activity in 26 patients with poor risk malignancies", Cancer Chemotherapy Pharmacology, 13, 588–595.
   Google Scholar
• Wheeler, C., Antin, J.H., Churchill, W.H. et al. (1990) "Cyclopho-sphamide, carmustine and etoposide with autologous bone marrow transplantation in refractory Hodgkin's disease and non-Hodgkin's lymphoma. A dose finding study", Journal of Clinical Oncology, 8, 648 —656.
   PubMed Web of Science ®Google Scholar
• Haioun, C., Lepage, E., Gisselbrecht, C., et al. (1994) "Comparison of autologous bone marrow transplantation with sequential chemotherapy for intermediate grade and high-grade non-Hodg-kin's lymphoma in first complete remission", Journal of Clinical Oncology, 12, 2543–2551.
   Google Scholar
• Todd, NW., Peters, W.P., Ost, A.H., Roggli, V.L. and Piantadosi, CA. (1993) "Pulmonary drug toxicity in patients with primary breast cancer treated with high dose combination chemotherapy and autologous bone marrow transplantation", The American Review of Respiratory Disease, 147, 1264–1270.
   Google Scholar
• Jones, R.B., Matthes, S., Shpall, E.J., Fisher, J.H., Stemmer, S.M., Duffont, C., et al. (1993) "Acute lung injury following treatment with high dose cyclophosphamide, cisplatin and carmustine: pharmacodynamic evaluation of carmustine", Journal of the National Cancer Institute, 85, 640–647.
   PubMed Web of Science ®Google Scholar
• Babson, J.R. and Reed, D.J. (1978) "Inactivation of glutathione reductase by 2-chloroethyl nitrosourea-derived isocyanates", Bio-chemical and Biophysical Research Communications, 83, 754–762.
   PubMed Web of Science ®Google Scholar
• Friedman, H.S., Colvin, O.M., Aisaka, K., Popp, J., Bossen, E.H., Reimer, K.A., et al. (1990) "Glutathione protects cardiac and skeletal muscle from cyclophosphamide-induced toxicity", Cancer Research, 50, 2455–2462.
   Google Scholar
• Seiden, MN., Elias, A., Ayash, L., Hunt, M., Elder, J.P., Snnipper, L.E., et al. (1992) "Pulmonary toxicity associated with high dose chemotherapy in the treatment of solid tumors with autologous marrow transplantation: analysis of four chemotherapy regimens", Bone Marrow Transplant, 10, 57–63.
   PubMed Web of Science ®Google Scholar
• Van Besien, K., Tabocokk, J., Rodriguez, M., Andersson, B., Mehra, R., Przepiorka, D. et al. (1995) "High dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen related toxicity", Bone Marrow Transplant, 15, 549–555.
   Google Scholar
• Fisher, B., Slack, N., Katrych, D., et al. (1975) "Ten year follow-up results of patients with carcinoma of the breast in a co-operative clinical trial evaluating surgical adjuvant chemotherapy", Surgery, Gynecology Obstetrics, 140, 528–534.
   Google Scholar
• Lazarus, H.M., Reed, M.D., Spitzer, T.R. et al. (1987) "High dose i.v thiotepa and cryopreserved autologous bone marrow transplan-tation for therapy of refractory cancer", Cancer Treatment Reports, 71, 689–695.
   Google Scholar
• Wolff, S.N., Herzig, R.H., Fay, J.W. et al. (1989) "High dose thiotepa with autologous transplantation for metastatic malignant melanoma: results of phase I and II studies of the North American Bone Marrow Transplant Group", Journal of Clinical Oncology, 7, 245— 249.
   Google Scholar
• Antman, K., Ayash, L., Elias, A., et al. (1992) "Phase II study of high dose cyclophosphamide, thiotepa and carboplatin with autologous marrow support in women with measurable advanced breast cancer responding to standard dose therapy", Journal of Clinical Oncology, 10, 102 — 110.
   Google Scholar
• Rodenhuis, S., Baars, J.W., Schornagel, J.H., et al. (1992) "Feasibility and toxicity study of high dose chemotherapy regimen for auto-transplantation incorporating carboplatin, cyclophospha-mide and thiotepa", Annals of Oncology, 3, 855–860.
   Google Scholar
• Shea, T.C., Flaherty, M., Elias, A., et al. (1989) "A phase I clinical and pharmacokinetic study of carboplatin and autologous bone marrow support", Journal of Clinical Oncology, 7, 651–661.
   Google Scholar
• Calvert, A.H., Newell, DR., Gumbrell, L.A., et al. (1989) "Carboplatin dosage: prospective evaluation of a simple formula based on renal function", Journal of Clinical Oncology, 7, 1748–1756.
   Google Scholar
• Jodrell, DI., Egorin, M.J., Canetta, R.M. et al. (1992) "Relation-ships between carboplatin exposure and tumor response and toxicity in patients with ovarian cancer", Journal of Clinical Oncology, 10, 520— 528.
   Google Scholar
• Schilder, R.J., Johnson, S., Gallo, J., et al. (1999) "Phase I trial of multiple cycles of high dose chemotherapy supported by autologous peripheral stem cells", Journal of Clinical Oncology, 17, 2198 —2207.
   Google Scholar
• Mazumdar, M., Smith, A., Tong, W.P., et al. (2000) "Calvert's formula for dosing carboplatin: overview and concerns of applic-ability in high dose setting", Journal of the National Cancer Institute, 92, 1434 — 1436.
   PubMed Web of Science ®Google Scholar
• Allan, S.G., Cummings, J., Evans, S., et al. (1991) "Phase I study of anthrapyrazole biantrazole: clinical results and pharmacology", Cancer Chemotherapy and Pharmacology, 28, 55–58.
   PubMed Web of Science ®Google Scholar
• Talbot, D.C., Smith, I.E., Mansi, J.L., et al. (1991) "Anthrapyrazole C1941: a highly active new agent in the treatment of advanced breast cancer", Journal of Clinical Oncology, 9, 2141–2147.
   Google Scholar
• Feldman, E.J., Alberts, D.S., Ahmed, T., et al. (1993) "Phase I clinical and pharmacokinetic evaluation of high-dose mitoxantrone in combination with cytarabine in patients with acute leukemia", Journal of Clinical Oncology, 11, 2002–2009.
   Web of Science ®Google Scholar
• Mollgard, L., Tidefelt, U., Paul, C., et al. (1998) "High single dose of mitoxantrone and cytarabine in acute non-lymphocytic leukemia: a pharmacokinetic and clinical study", Therapeutic Drug Monitor-ing, 20, 640–645.
   PubMed Web of Science ®Google Scholar
• Geisler, C.H., Mork Hansen, M., Andersen, N.S., Ravn Juhl, B., et al. (1998) "BEAM + autologous stem cell transplantation in malignant lymphoma: 100 consecutive transplants in a single centre. Efficacy, toxicity and engraftment in relation to stem cell source and previous treatment", European Journal of Hematology, 61, 173 — 182.
   Google Scholar
• Weaver, C.H., Schwartzberg, L.S., Hainsworth, J., et al. (1997) "Treatment related mortality in 1000 consecutive patients receiving high dose chemotherapy and peripheral blood progenitor cell transplantation in community centers", Bone Marrow Transplanta-tion, 19, 671–678.
   PubMed Web of Science ®Google Scholar
• Deeg, H.J. and Socie, G. (1998) "Malignancies after hematopoietic stem cell transplantation: many questions, some answers", Blood, 91, 833 — 1844.
   Google Scholar
• Miller, J.S., Arthur, D.C., Litz, CE., Neglia, J.P., Miller, W.J. and Weisdorf, D.J. (1994) "Myelodysplastic syndrome after autologous bone marrow transplantation: an additional late complication of curative cancer therapy [see comments]", Blood, 83, 3780— 3786.
   Google Scholar
• Darrington, DL., Vose, J.M., Anderson, J.R., et al. (1994) "Incidence and characterization of secondary myelodysplastic syndrome and acute myelogenous leukemia following high dose chemo radiotherapy and autologous stem cell transplantation for lymphoid malignancies", Journal of Clinical Oncology, 12, 2527 — 2534.
   Google Scholar
• Wheeler, C., Khurshid, A., Antin, J., et al. (2001) "Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lym-phoma patients compared with Hodgkin's disease patients under-going autologous transplantation following cyclophosphamide, carmustine and etoposide (CBV)", Leukemia and Lymphoma, 50, 499–509.
   Google Scholar
• Stone, R.M., Neuberg, D., Soiffer, R., et al. (1994) "Myelodysplas-tic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma", Journal of Clinical Oncology, 12, 2535–2542.
   Google Scholar
• Oddou, S., Vey, N., Viens, P., Blaise, D., et al. (1998) "Second neoplasms following high dose chemotherapy and autologous stem cell transplantation for malignant lymphomas: a report of six cases in a cohort of 171 patients from a single institution", Leukemia and Lymphoma, 31, 187–194.
   Google Scholar